“…Immunofluorescence was carried out as described in detail previously (Sato et al, ; Sato et al, ; Sato et al, ). The following primary antibodies were used: rabbit anti‐ß‐Gal (dilution, 1:5,000, Covance, Berkeley, CA), chicken anti‐ß‐Gal (dilution, 1:1,000–2,000, Abcam, Cambridge, UK), mouse anti‐ISL1/2 (dilution, 1:150, mixture of hybridoma supernatants, 39.4D5 and 40.2D6, Developmental Studies Hybridoma Bank), guinea pig anti‐SIX1 (dilution, 1:5,000) (Ikeda et al, ), rat anti‐SIX1 (dilution, 1:2,000) (Konishi et al, ), guinea pig anti‐SOX10 (dilution, 1:5,000) (Yajima et al, ), mouse anti‐TUBB3 (tubulin, beta 3 class III, clone TuJ1, dilution, 1:5,000, Covance, Berkeley, CA), goat anti‐SOX2 (dilution 1:3,000, Santa Cruz Biotechnology, CA) and rabbit anti‐MYO7A (dilution 1:3,000, Proteus BioSciences, CA) antibodies. The secondary antibodies were fluorophore (Alexa Fluor 488, 546, 555, and 633)‐labeled species‐specific antibodies (dilution, 1:1,000–2,000) (Molecular Probes/Invitrogen and Amersham Biosciences).…”